About Variant Bio
Variant Bio is a company based in Brooklyn (United States) founded in 2018 by Stephane Castel and Kaja Wasik.. Variant Bio has raised $127.74 million across 3 funding rounds from investors including Lux Capital. Variant Bio offers products and services including Genomic Discovery Platform, Data Generation Services, and Ethical Research Collaborations. Variant Bio operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and Newtopia, among others.
- Headquarter Brooklyn, United States
- Founders Stephane Castel, Kaja Wasik
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$127.74 M (USD)
in 3 rounds
-
Latest Funding Round
$105 M (USD), Series B
Nov 17, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Variant Bio
Variant Bio offers a comprehensive portfolio of products and services, including Genomic Discovery Platform, Data Generation Services, and Ethical Research Collaborations. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing human genes to identify therapy targets.
Services for generating genomic data to support drug development.
Programs for ethical partnerships in genomics and benefit sharing.
Unlock access to complete
Unlock access to complete
Funding Insights of Variant Bio
Variant Bio has successfully raised a total of $127.74M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $105 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $105.0M
-
First Round
First Round
(10 Oct 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - Variant Bio | Valuation |
investors |
|
| Aug, 2020 | Amount | Series A - Variant Bio | Valuation |
investors |
|
| Oct, 2019 | Amount | Series A - Variant Bio | Valuation | Lux Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Variant Bio
Variant Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lux Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Variant Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Variant Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Variant Bio Comparisons
Competitors of Variant Bio
Variant Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and Newtopia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| domain | founded_year | HQ Location |
Health management platform is provided for employers and insurers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Variant Bio
Frequently Asked Questions about Variant Bio
When was Variant Bio founded?
Variant Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Variant Bio located?
Variant Bio is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Who is the current CEO of Variant Bio?
Andrew Farnum is the current CEO of Variant Bio.
Is Variant Bio a funded company?
Variant Bio is a funded company, having raised a total of $127.74M across 3 funding rounds to date. The company's 1st funding round was a Series A of $16.64M, raised on Oct 10, 2019.
What does Variant Bio do?
Variant Bio was founded in 2018 and is headquartered in Brooklyn, United States. The company operates in the biotechnology sector, focusing on genomics to address rare diseases. A platform is provided for detecting human genetic diversity, enabling the development of targeted treatment solutions. Services emphasize personalized therapeutics derived from genetic analysis to support therapeutic advancements in underserved medical areas.
Who are the top competitors of Variant Bio?
What products or services does Variant Bio offer?
Variant Bio offers Genomic Discovery Platform, Data Generation Services, and Ethical Research Collaborations.
Who are Variant Bio's investors?
Variant Bio has 1 investor. Key investors include Lux Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.